|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Á¦ ¸ñ |
swifiPGftzDMGP |
|
ÀÌ ¸§ |
Shayne |
³¯ Â¥ |
2018/06/28 |
Á¶ ȸ |
1 |
|
Sorry, you must have the wrong number atarax tablet usage Meanwhile, biopharma companies are increasingly challenged by scarce resources to conduct genomic biomarker analysis in-house. Following Dr. Crosby's talk, Dr. Sirosh Bokhari presents data from a recent study to validate data across multiple modalities for pipeline decision-making. The study was conducted to investigate the mechanisms of resistance to tyrosine kinase inhibition in non-small cell lung cancer cell lines with activating or resistance-conferring mutations.
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|